Cargando…

A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure

Background: Heart failure (HF) is a global problem responsible for significant morbidity and mortality. Methods: This review describes the patient pathways and missed opportunities related to treatment for patients with HF. Results: The contemporary management strategies in HF, including medical the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwok, Chun Shing, Satchithananda, Duwarakan, Ahmed, Fozia Z., Chue, Colin D., Barker, Diane, Patwala, Ashish, Duckett, Simon, Mallen, Christian D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784521/
https://www.ncbi.nlm.nih.gov/pubmed/36547452
http://dx.doi.org/10.3390/jcdd9120455
_version_ 1784857832233893888
author Kwok, Chun Shing
Satchithananda, Duwarakan
Ahmed, Fozia Z.
Chue, Colin D.
Barker, Diane
Patwala, Ashish
Duckett, Simon
Mallen, Christian D.
author_facet Kwok, Chun Shing
Satchithananda, Duwarakan
Ahmed, Fozia Z.
Chue, Colin D.
Barker, Diane
Patwala, Ashish
Duckett, Simon
Mallen, Christian D.
author_sort Kwok, Chun Shing
collection PubMed
description Background: Heart failure (HF) is a global problem responsible for significant morbidity and mortality. Methods: This review describes the patient pathways and missed opportunities related to treatment for patients with HF. Results: The contemporary management strategies in HF, including medical therapies, device therapy, transplant, and palliative care. Despite the strong evidence base for therapies that improve prognosis and symptoms, there remains a large number of patients that are not optimally managed. The treatment of patients with HF is highly influenced by those who are caring for them and varies widely across geographical regions. HF patients can be broadly classified into two key groups: those who have known HF, and those who are incidentally found to have reduced left ventricular systolic dysfunction or other cardiac abnormality when an echocardiogram is performed. While all patients are under the care of a general practitioner or family doctor, in other instances, non-cardiologist physicians, cardiologists, and specialist HF nurses—each will have varying levels of expertise in managing HF—are part of the broader team involved in the specialist management of patients with HF. Conclusions: There are many potential missed opportunities in HF treatment, which include general opportunities, medications, etiology-specific therapy, device therapy, therapies when initial treatments fail, and palliative care.
format Online
Article
Text
id pubmed-9784521
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97845212022-12-24 A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure Kwok, Chun Shing Satchithananda, Duwarakan Ahmed, Fozia Z. Chue, Colin D. Barker, Diane Patwala, Ashish Duckett, Simon Mallen, Christian D. J Cardiovasc Dev Dis Review Background: Heart failure (HF) is a global problem responsible for significant morbidity and mortality. Methods: This review describes the patient pathways and missed opportunities related to treatment for patients with HF. Results: The contemporary management strategies in HF, including medical therapies, device therapy, transplant, and palliative care. Despite the strong evidence base for therapies that improve prognosis and symptoms, there remains a large number of patients that are not optimally managed. The treatment of patients with HF is highly influenced by those who are caring for them and varies widely across geographical regions. HF patients can be broadly classified into two key groups: those who have known HF, and those who are incidentally found to have reduced left ventricular systolic dysfunction or other cardiac abnormality when an echocardiogram is performed. While all patients are under the care of a general practitioner or family doctor, in other instances, non-cardiologist physicians, cardiologists, and specialist HF nurses—each will have varying levels of expertise in managing HF—are part of the broader team involved in the specialist management of patients with HF. Conclusions: There are many potential missed opportunities in HF treatment, which include general opportunities, medications, etiology-specific therapy, device therapy, therapies when initial treatments fail, and palliative care. MDPI 2022-12-12 /pmc/articles/PMC9784521/ /pubmed/36547452 http://dx.doi.org/10.3390/jcdd9120455 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Kwok, Chun Shing
Satchithananda, Duwarakan
Ahmed, Fozia Z.
Chue, Colin D.
Barker, Diane
Patwala, Ashish
Duckett, Simon
Mallen, Christian D.
A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title_full A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title_fullStr A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title_full_unstemmed A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title_short A Critical Evaluation of Patient Pathways and Missed Opportunities in Treatment for Heart Failure
title_sort critical evaluation of patient pathways and missed opportunities in treatment for heart failure
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784521/
https://www.ncbi.nlm.nih.gov/pubmed/36547452
http://dx.doi.org/10.3390/jcdd9120455
work_keys_str_mv AT kwokchunshing acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT satchithanandaduwarakan acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT ahmedfoziaz acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT chuecolind acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT barkerdiane acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT patwalaashish acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT duckettsimon acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT mallenchristiand acriticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT kwokchunshing criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT satchithanandaduwarakan criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT ahmedfoziaz criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT chuecolind criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT barkerdiane criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT patwalaashish criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT duckettsimon criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure
AT mallenchristiand criticalevaluationofpatientpathwaysandmissedopportunitiesintreatmentforheartfailure